NSEUpdates26 Sept 2026 · 26 Sept 2026, 04:57 pm

Updates

Unichem Laboratories Limited · UNICHEMLAB

✦ AI SummaryRegulatory

Unichem Laboratories Limited has informed the Exchange regarding USFDA Inspection At Goa Formulation Facility, where the inspection concluded with five observations related to procedural enhancements, and the company will provide a response within 15 days.

Analysis Scores

Earnings Impact2/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk6/10

Balance Sheet Risk1/10

Liquidity Impact8/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Unichem Laboratories Limited has informed the Exchange regarding USFDA Inspection At Goa Formulation Facility

Attachments (1)

📄

UNICHEMLAB_26092026165524_IntimationtoSE.pdf

pdf

Download →

View document text

26th September 2026 BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring Exchange Plaza, Rotunda Building, P J Tower Bandra Kurla Complex Dalal Street, Fort, Bandra East MUMBAI – 400 001 MUMBAI – 400 051 BSE Scrip Code – 506690 NSE Symbol – UNICHEMLAB Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, The United States Food and Drug Administration (USFDA) conducted an inspection at the Company’s Goa Formulation facility situated at Pilerne, Bardez from 21st September 2026 to 26th September 2026. The inspection concluded with five (5) observations related to procedural enhancements. The Company will provide the necessary response to USFDA within stipulated 15 days. You are requested to kindly take the same on your records. Thanking you, For UNICHEM LABORATORIES LIMITED PRADEEP BHANDARI Head – Legal & Company Secretary Registered Office: .